The ketogenic diet is a promising adjuvant cancer therapy that can sensitize most cancers to standard treatment. Preclinical and clinical studies suggest that the ketogenic diet can enhance the antitumor effects of classic chemo- and radiotherapy and increase the quality of life of cancer patients. However, more molecular studies and uniformly controlled clinical trials are needed to fully understand the mechanisms of the ketogenic diet as a cancer therapy and its application in clinical practice.